184 related articles for article (PubMed ID: 31151473)
1. RTS,S malaria vaccine pilot studies: addressing the human realities in large-scale clinical trials.
van den Berg M; Ogutu B; Sewankambo NK; Biller-Andorno N; Tanner M
Trials; 2019 May; 20(1):316. PubMed ID: 31151473
[TBL] [Abstract][Full Text] [Related]
2. Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
Hogan AB; Winskill P; Ghani AC
PLoS Med; 2020 Nov; 17(11):e1003377. PubMed ID: 33253211
[TBL] [Abstract][Full Text] [Related]
3. Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
Baral R; Levin A; Odero C; Pecenka C; Tabu C; Mwendo E; Bonsu G; Bawa J; Dadzie JF; Charo J; Antwi-Agyei KO; Amponsa-Achianou K; Jalango RE; Mkisi R; Gordon S; Mzengeza T; Morgan W; Muhib F
PLoS One; 2021; 16(1):e0244995. PubMed ID: 33428635
[TBL] [Abstract][Full Text] [Related]
4. Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic review.
Dimala CA; Kika BT; Kadia BM; Blencowe H
PLoS One; 2018; 13(12):e0209744. PubMed ID: 30596732
[TBL] [Abstract][Full Text] [Related]
5. Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01
Grant J; Gyan T; Agbokey F; Webster J; Greenwood B; Asante KP
Malar J; 2022 May; 21(1):147. PubMed ID: 35550113
[TBL] [Abstract][Full Text] [Related]
6. Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.
Agnandji ST; Fernandes JF; Bache EB; Ramharter M
Future Microbiol; 2015; 10(10):1553-78. PubMed ID: 26437872
[TBL] [Abstract][Full Text] [Related]
7. RTS,S malaria vaccine pilots in three African countries.
Adepoju P
Lancet; 2019 Apr; 393(10182):1685. PubMed ID: 31034365
[No Abstract] [Full Text] [Related]
8. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination.
Vandoolaeghe P; Schuerman L
Expert Rev Vaccines; 2016 Dec; 15(12):1481-1493. PubMed ID: 27841689
[TBL] [Abstract][Full Text] [Related]
9. Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study.
Sauboin CJ; Van Bellinghen LA; Van De Velde N; Van Vlaenderen I
Malar J; 2015 Dec; 14():524. PubMed ID: 26702637
[TBL] [Abstract][Full Text] [Related]
10. RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi.
Han L; Hudgens MG; Emch ME; Juliano JJ; Keeler C; Martinson F; Kamthunzi P; Tegha G; Lievens M; Hoffman IF
Sci Rep; 2017 Aug; 7(1):7200. PubMed ID: 28775306
[TBL] [Abstract][Full Text] [Related]
11. Barriers and facilitators to nationwide implementation of the malaria vaccine in Ghana.
Adeshina OO; Nyame S; Milner J; Milojevic A; Asante KP
Health Policy Plan; 2023 Jan; 38(1):28-37. PubMed ID: 36083007
[TBL] [Abstract][Full Text] [Related]
12. The Ethics of Health Care Delivery in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania.
Ward CL; Shaw D; Anane-Sarpong E; Sankoh O; Tanner M; Elger B
J Empir Res Hum Res Ethics; 2018 Feb; 13(1):26-41. PubMed ID: 29179625
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Implementation Determinants of Pilot Malaria Vaccination Programs in Ghana, Kenya, and Malawi through a Complexity Lens: A Rapid Review Using a Consolidated Framework for Implementation Research.
Adamu AA; Jalo RI; Ndwandwe D; Wiysonge CS
Vaccines (Basel); 2024 Jan; 12(2):. PubMed ID: 38400095
[TBL] [Abstract][Full Text] [Related]
14. [The malaria vaccine candidate RTS,S/AS is in phase III clinical trials].
Cohen J; Benns S; Vekemans J; Leach A
Ann Pharm Fr; 2010 Nov; 68(6):370-9. PubMed ID: 21073995
[TBL] [Abstract][Full Text] [Related]
15. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
Mamotte N; Wassenaar D; Koen J; Essack Z
BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
[TBL] [Abstract][Full Text] [Related]
16. [The RTS,S/AS01 malaria vaccine in children aged 5-17 months at first vaccination].
Vandoolaeghe P; Schuerman L
Pan Afr Med J; 2018; 30():142. PubMed ID: 30374388
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66.
Bojang KA; Obaro SK; Leach A; D'Alessandro U; Bennett S; Metzger W; Ballou WR; Targett GA; Greenwood BM
Parasite Immunol; 1997 Dec; 19(12):579-81. PubMed ID: 9458470
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
[TBL] [Abstract][Full Text] [Related]
19. Malaria vaccine: a step toward elimination.
Jindal H; Bhatt B; Malik JS; Sk S; Mehta B
Hum Vaccin Immunother; 2014; 10(6):1752-4. PubMed ID: 24643280
[TBL] [Abstract][Full Text] [Related]
20. Post introduction evaluation of the malaria vaccine implementation programme in Ghana, 2021.
Adjei MR; Amponsa-Achiano K; Okine R; Tweneboah PO; Sally ET; Dadzie JF; Osei-Sarpong F; Adjabeng MJ; Bawa JT; Bonsu G; Antwi-Agyei KO; Kaburi BB; Owusu-Antwi F; Juma E; Kasolo FC; Asiedu-Bekoe F; Kuma-Aboagye P
BMC Public Health; 2023 Mar; 23(1):586. PubMed ID: 36991394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
